Recent News

• 02.28.2025 - Q4 2024 Fulgent Genetics Earnings Conference Call
• 02.28.2025 - Q4 2024 Fulgent Genetics Earnings Conference Call
• 02.28.2025 - Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.28.2025 - Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.06.2025 - Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025
• 02.06.2025 - Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025
• 02.04.2025 - Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics
• 02.04.2025 - Foundation Medicine to Launch Hereditary Germline Tests, FoundationOne®Germline and FoundationOne®Germline More, in the United States Through a Partnership with Fulgent Genetics

Recent Filings

• 02.28.2025 - 8-K Current report
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.28.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities